These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7249794)

  • 1. Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life.
    Stoeckel K
    Chemotherapy; 1981; 27 Suppl 1():42-6. PubMed ID: 7249794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.
    Stoeckel K; McNamara PJ; Brandt R; Plozza-Nottebrock H; Ziegler WH
    Clin Pharmacol Ther; 1981 May; 29(5):650-7. PubMed ID: 7053242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients.
    Schleibinger M; Steinbach CL; Töpper C; Kratzer A; Liebchen U; Kees F; Salzberger B; Kees MG
    Br J Clin Pharmacol; 2015 Sep; 80(3):525-33. PubMed ID: 25808018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics and safety of high doses of ceforanide (BL-S786R) and cefazolin.
    Smyth RD; Pfeffer M; Glick A; Van Harken DR; Hottendorf GH
    Antimicrob Agents Chemother; 1979 Nov; 16(5):615-21. PubMed ID: 526003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration.
    Lakings DB; Novak E; Friis JM; Lunan CM; Paxton LM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):271-7. PubMed ID: 3717932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefotaxime.
    Fu KP; Aswapokee P; Ho I; Matthijssen C; Neu HC
    Antimicrob Agents Chemother; 1979 Nov; 16(5):592-7. PubMed ID: 526000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a new cephalosporin, CGP 9000 (cefroxadine), in healthy volunteers.
    Bergan T
    Chemotherapy; 1980; 26(4):225-30. PubMed ID: 7389422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ceftriaxone in humans.
    Patel IH; Chen S; Parsonnet M; Hackman MR; Brooks MA; Konikoff J; Kaplan SA
    Antimicrob Agents Chemother; 1981 Nov; 20(5):634-41. PubMed ID: 6275779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefepime: a review.
    Van der Auwera P; Santella PJ
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():103-15. PubMed ID: 8150753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition kinetics and dosage regimen of ceftriaxone in crossbred calves (short communication).
    Johal B; Srivastava AK
    Acta Vet Hung; 1999; 47(2):243-8. PubMed ID: 10344084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
    Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
    Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cephanone in healthy adult volunteers.
    Regamey C; Kirby WM
    Antimicrob Agents Chemother; 1973 Dec; 4(6):589-92. PubMed ID: 4793878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.
    Seddon M; Wise R; Gillett AP; Livingston R
    Antimicrob Agents Chemother; 1980 Aug; 18(2):240-2. PubMed ID: 7447404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose.
    McNamara PJ; Stoeckel K; Ziegler WH
    Eur J Clin Pharmacol; 1982; 22(1):71-5. PubMed ID: 6284519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlinear pharmacokinetics of DQ-2556, a new 3-quaternary ammonium cephalosporin antibiotic, in rats caused by non-Michaelis-Menten type, dose-dependent renal clearance.
    Matsubayashi K; Shintani S; Yoshida K; Yamada M; Tachizawa H
    J Pharm Sci; 1994 Feb; 83(2):186-92. PubMed ID: 8169786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefodizime in patients with various degrees of renal failure.
    Loffreda A; Lampa E; Lucarelli C; Amorena M; Contaldi C; Calderaro V; Rossi F
    Chemotherapy; 1999; 45(1):1-7. PubMed ID: 9876203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of cefuroxime after intravenous injection.
    Gower PE; Dash CH
    Eur J Clin Pharmacol; 1977 Nov; 12(3):221-7. PubMed ID: 590309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefotaxime kinetics after multiple-dose intramuscular study in healthy volunteers.
    Harvengt C; Wauters G; Meunier H
    Chemotherapy; 1981; 27(3):173-8. PubMed ID: 6262022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency.
    Humbert G; Leroy A; Fillastre JP; Godin M
    Chemotherapy; 1979; 25(4):189-95. PubMed ID: 456077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.